SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-20-000061
Filing Date
2020-04-03
Accepted
2020-04-03 16:25:58
Documents
14
Period of Report
2020-04-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a202004038k.htm   iXBRL 8-K 42205
  Complete submission text file 0000819050-20-000061.txt   187899

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20200403.xsd EX-101.SCH 4436
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20200403_cal.xml EX-101.CAL 617
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20200403_def.xml EX-101.DEF 1467
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20200403_lab.xml EX-101.LAB 27263
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20200403_pre.xml EX-101.PRE 14107
15 EXTRACTED XBRL INSTANCE DOCUMENT a202004038k_htm.xml XML 4406
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 20773701
SIC: 2836 Biological Products, (No Diagnostic Substances)